Literature DB >> 18941175

A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections.

Wanwisa Dejnirattisai1, Thaneeya Duangchinda, Chen-Lung Steve Lin, Sirijitt Vasanawathana, Meleri Jones, Michael Jacobs, Prida Malasit, Xiao-ning Xu, Gavin Screaton, Juthathip Mongkolsapaya.   

Abstract

Severe dengue virus (DV) infections can cause the life-threatening condition dengue hemorrhagic fever, which is characterized by a severe plasma leak, thrombocytopenia, hemorrhage, and, in severe cases, circulatory collapse and death. There is now much evidence that pre-existing immunity to DV can enhance disease when an individual becomes infected on a second or sequential occasion. It has been shown that in contrast to infected dendritic cells (DC), noninfected bystander DC underwent maturation in dengue infection. In this study, we show that TNF-alpha and type I IFN contribute to the maturation of bystander DC, whereas the inhibition of DV-infected DC maturation can be overcome by activated T cells. Furthermore, IFN-gamma-inducible chemokines, CXCL9, 10, and 11 produced by infected DC are greatly amplified in the presence of DV-specific T cells. The chemokine secretion is also enhanced in coculture of HUVEC with either DV-infected DC or activated T cells. Finally, we found a close correlation between the serum level of these three chemokines and disease severity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941175     DOI: 10.4049/jimmunol.181.9.5865

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance.

Authors:  Ashley L St John; Abhay P S Rathore; Han Yap; Mah-Lee Ng; Dean D Metcalfe; Subhash G Vasudevan; Soman N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

2.  Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation.

Authors:  Pachiappan Arjunan; Mohamed M Meghil; Wenhu Pi; Jinxian Xu; Liwei Lang; Ahmed El-Awady; William Sullivan; Mythilypriya Rajendran; Mariana Sousa Rabelo; Tong Wang; Omnia K Tawfik; Govindarajan Kunde-Ramamoorthy; Nagendra Singh; Thangaraju Muthusamy; Cristiano Susin; Yong Teng; Roger M Arce; Christopher W Cutler
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

3.  Decreased peripheral dendritic cell numbers in dengue virus infection.

Authors:  Marcelo De Carvalho Bittencourt; Jenny Martial; André Cabié; Laurent Thomas; Raymond Césaire
Journal:  J Clin Immunol       Date:  2011-10-04       Impact factor: 8.317

4.  Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells.

Authors:  Guilherme F Silveira; Florencia Meyer; Adriana Delfraro; Ana Luiza P Mosimann; Norma Coluchi; Cyntia Vasquez; Christian M Probst; André Báfica; Juliano Bordignon; Claudia N Duarte Dos Santos
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  Immunosuppressive effects and mechanisms of leflunomide in dengue virus infection of human dendritic cells.

Authors:  Wan-Lin Wu; Ling-Jun Ho; Pei-Chih Chen; Yi-Ting Tsai; Seng-Ting Hsu; Deh-Ming Chang; Jenn-Haung Lai
Journal:  J Clin Immunol       Date:  2011-08-17       Impact factor: 8.317

6.  A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Toi Pham Van; Sue J Lee; Jeremy Farrar; Bridget Wills; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

7.  The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.

Authors:  Lázaro Gil; Ernesto Marcos; Alienys Izquierdo; Laura Lazo; Iris Valdés; Peris Ambala; Lucy Ochola; Rikoi Hitler; Edith Suzarte; Mayling Álvarez; Prisilla Kimiti; James Ndung'u; Thomas Kariuki; María Guadalupe Guzmán; Gerardo Guillén; Lisset Hermida
Journal:  Immunol Cell Biol       Date:  2014-09-02       Impact factor: 5.126

8.  Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection.

Authors:  Erik L Brincks; Alan D Roberts; Tres Cookenham; Stewart Sell; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  J Immunol       Date:  2013-03-06       Impact factor: 5.422

9.  High-dimensional CyTOF analysis of dengue virus-infected human DCs reveals distinct viral signatures.

Authors:  Rebecca E Hamlin; Adeeb Rahman; Theodore R Pak; Kevin Maringer; Ignacio Mena; Dabeiba Bernal-Rubio; Uma Potla; Ana M Maestre; Anthony C Fredericks; El-Ad D Amir; Andrew Kasarskis; Irene Ramos; Miriam Merad; Ana Fernandez-Sesma
Journal:  JCI Insight       Date:  2017-07-06

10.  Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response.

Authors:  G F Silveira; D M Strottmann; L de Borba; D S Mansur; N I T Zanchin; J Bordignon; C N Duarte dos Santos
Journal:  Clin Exp Immunol       Date:  2015-10-18       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.